GoAI
Get started
BIO-key International, Inc. logo

BIO-key International, Inc.

BKYI

NASDAQTechnologyInformation Technology Services

Open in GoAI

Previous close

$3.07

−$0.03 · -0.97%

Aug 21, 4:00 PM ET

BKYI company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

45

Fair Value

Momentum

33

Weakening

Sentiment

59

Mixed

Risk resilience

34

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.

Industry
Information Technology Services
Sector
Technology
Headquarters
US
CEO
Michael W. DePasquale
Listed since
Feb 21, 1997
Employees
42

Market position

Day range

Current $3.07

52-week range

Current $3.07

Open
$3.09
Previous close
$3.10
Volume
23.32K
0.35× average
Average volume
66.43K
Average daily volume
Market cap
3.33M USD
Beta
0.43
Market reference 1
50-day average
$4.2468
-27.71% below average
200-day average
$5.7112
-46.25% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-0.63×
P/B (TTM)
0.73×
P/S (TTM)
0.49×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
81.75%
Operating margin
-46.42%
Net margin
-50.00%

Financial health

Debt / equity
0.03×
Altman Z-score
-25.4
Piotroski F-score
2 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends106%6%-94%-195%Gross margin, FY2021: 67.29%Gross margin, FY2022: 65.25%Gross margin, FY2023: 18.46%Gross margin, FY2024: 81.39%Gross margin, FY2025: 77.47%Operating margin, FY2021: -96.62%Operating margin, FY2022: -141.36%Operating margin, FY2023: -113.82%Operating margin, FY2024: -57.88%Operating margin, FY2025: -69.89%Net margin, FY2021: -99.05%Net margin, FY2022: -169.65%Net margin, FY2023: -109.89%Net margin, FY2024: -62.06%Net margin, FY2025: -75.31%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 67.29%. Gross margin FY2022 65.25%. Gross margin FY2023 18.46%. Gross margin FY2024 81.39%. Gross margin FY2025 77.47%. Operating margin FY2021 -96.62%. Operating margin FY2022 -141.36%. Operating margin FY2023 -113.82%. Operating margin FY2024 -57.88%. Operating margin FY2025 -69.89%. Net margin FY2021 -99.05%. Net margin FY2022 -169.65%. Net margin FY2023 -109.89%. Net margin FY2024 -62.06%. Net margin FY2025 -75.31%.

Income trends

Revenue

6.1M USD-12.04%

Operating income

−4.26M USD-6.21%

Net income

−4.59M USD-6.74%
Income trends across reported periods9.72M USD1.86M USD−6.01M USD−13.88M USDRevenue, FY2021: 5.11M USDRevenue, FY2022: 7.02M USDRevenue, FY2023: 7.75M USDRevenue, FY2024: 6.93M USDRevenue, FY2025: 6.1M USDOperating income, FY2021: −4.94M USDOperating income, FY2022: −9.92M USDOperating income, FY2023: −8.83M USDOperating income, FY2024: −4.01M USDOperating income, FY2025: −4.26M USDNet income, FY2021: −5.07M USDNet income, FY2022: −11.91M USDNet income, FY2023: −8.52M USDNet income, FY2024: −4.3M USDNet income, FY2025: −4.59M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 5.11M USD. Revenue FY2022 7.02M USD. Revenue FY2023 7.75M USD. Revenue FY2024 6.93M USD. Revenue FY2025 6.1M USD. Operating income FY2021 −4.94M USD. Operating income FY2022 −9.92M USD. Operating income FY2023 −8.83M USD. Operating income FY2024 −4.01M USD. Operating income FY2025 −4.26M USD. Net income FY2021 −5.07M USD. Net income FY2022 −11.91M USD. Net income FY2023 −8.52M USD. Net income FY2024 −4.3M USD. Net income FY2025 −4.59M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue6.1M USD6.93M USD7.75M USD7.02M USD5.11M USD
Cost of goods sold1.37M USD1.29M USD6.32M USD2.44M USD1.67M USD
Gross profit4.72M USD5.64M USD1.43M USD4.58M USD3.44M USD
Research and development2.61M USD2.51M USD2.39M USD3.25M USD2.36M USD
Selling, general, and administrative6.37M USD7.14M USD7.86M USD9.36M USD6.03M USD
Operating expenses8.98M USD9.65M USD10.26M USD14.5M USD8.38M USD
Interest income3.79K USD110 USD11.53K USD233 USD4.08K USD
Interest expense317.63K USD299.76K USD218.27K USD10.46K USD18K USD
Depreciation and amortization377.15K USD477.53K USD590.14K USD546.01K USD514.07K USD
Operating income−4.26M USD−4.01M USD−8.83M USD−9.92M USD−4.94M USD
Net income−4.59M USD−4.3M USD−8.52M USD−11.91M USD−5.07M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
27%
3 beats, 7 misses, 1 met estimate
Average EPS surprise
-92.52%
11 comparable reports
Latest EPS result
-0.56
Estimate -0.82 · Beat by 31.71%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.13-1.99-3.85-5.71Q1 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 27, 2025: actual -5.3, estimate -3.5, surprise -51.43%, Miss. Q2 2025, reported May 15, 2025: actual -1.6, estimate -2.4, surprise +33.33%, Beat. Q3 2025, reported Aug 13, 2025: actual -2, estimate -1.5, surprise -33.33%, Miss. Q4 2025, reported Nov 14, 2025: actual -1.5, estimate -1.2, surprise -25.00%, Miss. Q1 2026, reported Mar 31, 2026: actual -1.9, estimate -0.7, surprise -171.43%, Miss. Q2 2026, reported May 18, 2026: actual -0.15, estimate -0.6, surprise +75.00%, Beat. Q3 2026, reported Aug 13, 2026: actual -0.56, estimate -0.82, surprise +31.71%, Beat. Q4 2026, reported Nov 13, 2026: actual —, estimate -0.35, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates2.5M2.05M1.6M1.15MQ1 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 27, 2025: actual 1.46M USD, estimate 2.3M USD, surprise -36.42%, Miss. Q2 2025, reported May 15, 2025: actual 1.61M USD, estimate 1.3M USD, surprise +23.63%, Beat. Q3 2025, reported Aug 13, 2025: actual 1.7M USD, estimate 1.7M USD, surprise -0.18%, Miss. Q4 2025, reported Nov 14, 2025: actual 1.55M USD, estimate 1.8M USD, surprise -13.91%, Miss. Q1 2026, reported Mar 31, 2026: actual 1.24M USD, estimate 2.2M USD, surprise -43.58%, Miss. Q2 2026, reported May 18, 2026: actual 2.15M USD, estimate 2.2M USD, surprise -2.48%, Miss. Q3 2026, reported Aug 13, 2026: actual 1.92M USD, estimate 1.8M USD, surprise +6.67%, Beat. Q4 2026, reported Nov 13, 2026: actual —, estimate 2.4M USD, surprise —, Comparison unavailable.

BKYI news

seekingalpha.com

BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcript

BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcript

Read source
globenewswire.com

BIO-key's Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

BIO-key's (BKYI)Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally.

Read source
globenewswire.com

BIO-key International Enters into $2.5 Million Warrant Inducement Transaction

HOLMDEL, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global innovator in Identity and Access Management (IAM) and biometric authentication solutions, today announced it has…

Read source
globenewswire.com

Portuguese National Security Agency Selects BIO-key and Visualforma to Strengthen Identity Security

Portuguese national security agency selects BIO-key (BKYI) and Visualforma to strengthen identity security with advanced IAM and biometric authentication.

Read source
globenewswire.com

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

HOLMDEL, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, will host its Q2'26 investor call…

Read source
globenewswire.com

BIO-key and Maktabi Tech Partner to Advance Identity Security Across Saudi Arabia's Education Sector

BIO-key's proven IAM platform and Maktabi Tech's education market leadership bring global best practices and regional expertise to schools in Saudi Arabia

Read source

Corporate actions

Corporate action history

Stock split

Effective Apr 30, 2026

1:10

Stock split

Effective Dec 21, 2023

1:18

Stock split

Effective Nov 20, 2020

1:8

Stock split

Effective Dec 29, 2016

1:12

Stock split

Effective Feb 6, 2015

1:2

Stock split

Effective Jul 25, 1997

2:1

BKYI peers

NVIDIA Corporation logo

NVDA

NVIDIA Corporation

$214.72

-0.98%

Apple Inc. logo

AAPL

Apple Inc.

$309.35

-0.63%

Microsoft Corporation logo

MSFT

Microsoft Corporation

$483.24

+0.43%

Broadcom Inc. logo

AVGO

Broadcom Inc.

$368.45

+1.21%

SK hynix Inc. logo

SKHY

SK hynix Inc.

$163.41

+0.20%

Micron Technology, Inc. logo

MU

Micron Technology, Inc.

$966.78

-0.77%

Continue in GoAI

Research BKYI

research.disclaimer